{"id":"W4293463343","doi":"10.1161/circulationaha.122.061533","title":"Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"Eisai; ARCA Biopharma; Daiichi-Sankyo; Zora Biosciences; American Heart Association; American Thoracic Society; Intarcia Therapeutics; Ionis Pharmaceuticals; National Institutes of Health; Regeneron Pharmaceuticals; Harvard Catalyst; Alnylam Pharmaceuticals; Novo Nordisk; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Servier; Bayer; CSL Behring; AstraZeneca; Bristol-Myers Squibb; Pfizer; Amgen; Bayer HealthCare; Kowa Company; Sanofi; Brigham and Women's Hospital; Janssen Research and Development; United States Agency for International Development","keywords":"Medicine; Intensive care unit; Venous thrombosis; Stroke (engine); Mechanical ventilation; Clinical endpoint; Thrombosis; Pulmonary embolism; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005447787,0.0001022397,0.0003142846,0.0001538851,0.0001648295,0.000007647099,0.00003435594,0.00004610938,0.00003258294],"category_scores_gemma":[0.008051132,0.0000923374,0.00003900483,0.0001834226,0.00009261987,0.0001042099,0.00004659159,0.0001009134,2.074135e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000205442,"about_ca_system_score_gemma":0.000224762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005190068,"about_ca_topic_score_gemma":0.000008057236,"domain_scores_codex":[0.9986731,0.0001477555,0.0003285057,0.0002901248,0.0003860809,0.0001743915],"domain_scores_gemma":[0.9983474,0.0009717412,0.000118604,0.000135583,0.0002972959,0.0001293575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002777694,0.000876266,0.9852449,0.0005670015,0.00007119482,0.000003363504,0.000647041,0.001334966,0.002665784,0.0001100877,0.000009580738,0.005692156],"study_design_scores_gemma":[0.009606441,0.001667961,0.9810785,0.00004973979,0.00004721521,0.000001745742,0.0000848601,0.004620895,0.00002859295,0.00260552,0.0001191392,0.00008936675],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889364,0.00005596302,0.007338446,0.001717159,0.00005242029,0.001846802,0.00003252463,0.00001674691,0.000003538736],"genre_scores_gemma":[0.9984807,0.00005281792,0.0002265202,0.0009543149,0.00002855074,0.0000811643,0.0001578258,0.00001464354,0.00000350355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00954426,"threshold_uncertainty_score":0.9638539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05458983670580277,"score_gpt":0.4044379480627477,"score_spread":0.3498481113569449,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}